Australia markets close in 3 hours 11 minutes

Spencer Pharmaceutical Inc. (SPPH)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
At close: 04:36PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -37.97
52-week change 30.00%
S&P500 52-week change 323.57%
52-week high 30.0001
52-week low 30.0000
50-day moving average 30.0000
200-day moving average 30.0000

Share statistics

Avg vol (3-month) 31.38k
Avg vol (10-day) 339.12k
Shares outstanding 5271.27M
Implied shares outstanding 6N/A
Float 8N/A
% held by insiders 10.00%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 20.04:1
Last split date 305 Oct 2009

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2010
Most-recent quarter (mrq)31 Dec 2010

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-142.08%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-943.2k
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)455.93k
Total cash per share (mrq)0
Total debt (mrq)1.17M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.28
Book value per share (mrq)-0.00

Cash flow statement

Operating cash flow (ttm)642.43k
Levered free cash flow (ttm)N/A